곽낙원 (서울대학교 의과대학)님의 논문 목록 | 한빛사논문 > 한빛사

곽낙원 님의 논문 목록

서울대학교 의과대학

CV File 52 kb

Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: An individual patient data meta-analysis
- Eur. Resp. J., Jul 17 2025, 2500315 | https://doi.org/10.1183/13993003.00315-2025
- 2025-07
- 의약학
- 한빛사논문
Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort
- Clin. Infect. Dis., Apr 02 2024, ciae131 | https://doi.org/10.1093/cid/ciae131
- 2024-04
- 의약학
- 한빛사논문
Outcomes of Adjunctive Surgery in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-analysis
- Chest, 2022 Oct 5;S0012-3692(22)03907-1 | doi: 10.1016/j.chest.2022.09.037
- 2022-10
- 의약학
- 한빛사논문
Deep Learning-Based Prediction Model Using Radiography in Nontuberculous Mycobacterial Pulmonary Disease
- Chest, 2022 Jun 28;S0012-3692(22)01188-6. | https://doi.org/10.1016/j.chest.2022.06.018
- 2022-06
- 의약학
- 한빛사논문
Anxiety and depression in patients with nontuberculous mycobacterial pulmonary disease: a prospective cohort study in South Korea
- Chest, Available online 28 October 2021 | https://doi.org/10.1016/j.chest.2021.10.024
- 2021-10
- 의약학
- 한빛사논문
BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease
- Am. J. Respir. Crit. Care Med., January 15 2021, Volume 203, Issue 2 | https://doi.org/10.1164/rccm.202004-1418OC
- 2021-01
- 의약학
- 한빛사논문
Changes in treatment for multidrug-resistant tuberculosis according to national income
- Eur. Resp. J., Published online November 5, 2020 | https://doi.org/10.1183/13993003.01394-2020
- 2020-11
- 의약학
- 한빛사논문
Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
- Eur. Resp. J., Published online July 11, 2019, 54: 1801991 | DOI: 10.1183/13993003.01991-2018
- 2019-07
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기